Literature DB >> 19703637

Depression Care for People with Cancer: a collaborative care intervention.

Jane Walker1, Michael Sharpe.   

Abstract

Depression management for patients with chronic medical illnesses, including cancer, is often inadequate. "Depression Care for People with Cancer" (DCPC) has been designed to be integrated into specialist cancer services and is being evaluated in the Symptom Management Research Trials (SMaRT) Oncology series of randomized controlled trials. The intervention is an extended form of the collaborative care model and is delivered by a care manager, who receives regular supervision from a psychiatrist. The care manager coordinates the patient's depression management, by liaising with both their primary care physician and their cancer team, and provides a brief talking treatment. This article describes the design and delivery of DCPC as given in the SMaRT Oncology trials.

Entities:  

Mesh:

Year:  2009        PMID: 19703637     DOI: 10.1016/j.genhosppsych.2009.05.010

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  10 in total

Review 1.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

2.  Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics.

Authors:  Jacob T Painter; John C Fortney; Allen L Gifford; David Rimland; Thomas Monson; Maria C Rodriguez-Barradas; Jeffrey M Pyne
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

3.  Depression and undertreatment of depression: potential risks and outcomes in black patients with lung cancer.

Authors:  Lara Traeger; Sheila Cannon; William F Pirl; Elyse R Park
Journal:  J Psychosoc Oncol       Date:  2013

4.  Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis.

Authors:  Kuan-Yin Lin; Yu-Ting Hu; King-Jen Chang; Heui-Fen Lin; Jau-Yih Tsauo
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

5.  Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.

Authors:  A Duarte; J Walker; S Walker; G Richardson; C Holm Hansen; P Martin; G Murray; M Sculpher; M Sharpe
Journal:  J Psychosom Res       Date:  2015-11-09       Impact factor: 3.006

Review 6.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

7.  A simple filter model to guide the allocation of healthcare resources for improving the treatment of depression among cancer patients.

Authors:  Robert W Sanson-Fisher; Natasha E Noble; Andrew M Searles; Simon Deeming; Rochelle E Smits; Christopher J Oldmeadow; Jamie Bryant
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

8.  Is care really shared? A systematic review of collaborative care (shared care) interventions for adult cancer patients with depression.

Authors:  Joanne Shaw; Suvena Sethi; Lisa Vaccaro; Lisa Beatty; Laura Kirsten; David Kissane; Brian Kelly; Geoff Mitchell; Kerry Sherman; Jane Turner
Journal:  BMC Health Serv Res       Date:  2019-02-14       Impact factor: 2.655

9.  American Indian women cancer survivors' perceptions and experiences with conventional and non-conventional mental health care for depressive symptoms.

Authors:  Catherine E Burnette; Jessica Liddell; Soonhee Roh; Yeon-Shim Lee; Hee Yun Lee
Journal:  Ethn Health       Date:  2018-07-02       Impact factor: 2.772

10.  Linked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study.

Authors:  Marta Wanat; Jane Walker; Katy Burke; Nick Sevdalis; Alison Richardson; Amy Mulick; Chris Frost; Michael Sharpe
Journal:  BMJ Open       Date:  2017-07-02       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.